COMPASS PATHWAYS PLC Stock-Based Compensation
COMPASS PATHWAYS PLC (CMPS) reported Stock-Based Compensation of $6.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- COMPASS PATHWAYS PLC share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $4.03M, a 11.99% increase year-over-year.
- COMPASS PATHWAYS PLC share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.90M, a 26.40% decline year-over-year.
- COMPASS PATHWAYS PLC share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.85M, a 36.54% decline year-over-year.
- COMPASS PATHWAYS PLC share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.21M, a 35.51% decline year-over-year.
- COMPASS PATHWAYS PLC share-based payment arrangement, noncash expense for fiscal 2025 was $13.59M, a 30.37% decline from fiscal 2024.
- COMPASS PATHWAYS PLC share-based payment arrangement, noncash expense for fiscal 2024 was $19.52M, a 12.97% increase from fiscal 2023.
- COMPASS PATHWAYS PLC share-based payment arrangement, noncash expense for fiscal 2023 was $17.28M, a 31.65% increase from fiscal 2022.
- COMPASS PATHWAYS PLC share-based payment arrangement, noncash expense for fiscal 2022 was $13.12M, a 51.90% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.92M 10-Q · filed 2026-08-05 | $9.78M derived: sum of 3 quarters · filed 2026-08-05 | $12.98M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.90M 10-Q · filed 2026-05-13 | $5.75M derived: sum of 2 quarters · filed 2026-05-13 | $8.96M derived: sum of 3 quarters · filed 2026-05-13 | $12.55M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $6.06M derived: sum of 2 quarters · filed 2026-03-24 | $9.65M derived: sum of 3 quarters · filed 2026-08-05 | $13.59M 10-K · filed 2026-03-24 |
| 2025-09-30 | $3.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $6.80M derived: sum of 2 quarters · filed 2026-08-05 | $10.74M 10-Q · filed 2025-11-04 | $15.23M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $3.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.53M 10-Q · filed 2026-08-05 | $12.03M derived: sum of 3 quarters · filed 2026-08-05 | $17.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $3.94M 10-Q · filed 2026-05-13 | $8.43M derived: sum of 2 quarters · filed 2026-05-13 | $13.40M derived: sum of 3 quarters · filed 2026-05-13 | $18.32M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $9.47M derived: sum of 2 quarters · filed 2026-03-24 | $14.39M derived: sum of 3 quarters · filed 2026-03-24 | $19.52M 10-K · filed 2026-03-24 |
| 2024-09-30 | $4.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $9.89M derived: sum of 2 quarters · filed 2025-11-04 | $15.02M 10-Q · filed 2025-11-04 | $19.22M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $4.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $10.05M 10-Q · filed 2025-07-31 | $14.25M derived: sum of 3 quarters · filed 2025-07-31 | $18.70M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $5.13M 10-Q · filed 2025-05-08 | $9.33M derived: sum of 2 quarters · filed 2025-05-08 | $13.77M derived: sum of 3 quarters · filed 2025-05-08 | $18.34M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $8.64M derived: sum of 2 quarters · filed 2025-02-27 | $13.21M derived: sum of 3 quarters · filed 2025-02-27 | $17.28M 10-K · filed 2025-02-27 |
| 2023-09-30 | $4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $9.01M derived: sum of 2 quarters · filed 2024-10-31 | $13.08M 10-Q · filed 2024-10-31 | $16.39M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $4.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $8.63M 10-Q · filed 2024-08-01 | $11.95M derived: sum of 3 quarters · filed 2024-08-01 | $15.45M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $4.07M 10-Q · filed 2024-05-08 | $7.38M derived: sum of 2 quarters · filed 2024-05-08 | $10.89M derived: sum of 3 quarters · filed 2024-05-08 | $14.07M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $6.82M derived: sum of 2 quarters · filed 2024-02-29 | $9.99M derived: sum of 3 quarters · filed 2024-02-29 | $13.12M 10-K · filed 2024-02-29 |
| 2022-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $6.68M derived: sum of 2 quarters · filed 2023-11-02 | $9.81M 10-Q · filed 2023-11-02 | $12.59M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $6.31M 10-Q · filed 2023-08-03 | $9.09M derived: sum of 3 quarters · filed 2024-02-29 | $11.38M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $3.13M 10-Q · filed 2023-05-11 | $5.91M derived: sum of 2 quarters · filed 2024-02-29 | $8.20M derived: sum of 3 quarters · filed 2024-02-29 | $10.10M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $5.07M derived: sum of 2 quarters · filed 2024-02-29 | $6.97M derived: sum of 3 quarters · filed 2024-02-29 | $8.64M 10-K · filed 2024-02-29 |
| 2021-09-30 | $2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $4.19M derived: sum of 2 quarters · filed 2022-11-03 | $5.86M 10-Q · filed 2022-11-03 | $7.22M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.57M 10-Q · filed 2022-08-04 | $4.94M derived: sum of 3 quarters · filed 2023-02-28 | $10.15M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $1.67M 10-Q · filed 2022-05-10 | $3.03M derived: sum of 2 quarters · filed 2023-02-28 | $8.25M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | $1.37M derived: 10-K 12 month − 6-K 9 month · filed 2023-02-28 | $6.58M derived: sum of 2 quarters · filed 2023-02-28 | $17.98M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $5.21M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | $16.62M 6-K · filed 2021-11-09 | ||
| 2020-06-30 | $11.40M 6-K · filed 2021-08-11 | |||
| 2019-12-31 | $3.25M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |